BRCA1 and ovarian carcinoma: Epigenetic (i.e. DNA methylation, DNAme) changes have been identified in normal fimbriae from women with BRCA1/2 germline mutations14 and could potentially serve as surrogate markers for both genetic and non-genetic factors including lifestyle, reproductive, and environmental exposures contributing to ovarian cancer development15.